Asia-Pacific Medical Device Coating Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Device Material Type (Polymer, Metal, and Others), Devices (Medical Equipment and Tools, Medical Devices, Medical Implant, and Others), Coating (Hydrophilic Coating, Anti-Microbial Coating, Drug-Eluting Coating, Anti-Thrombogenic Coating, and Others), and Application (Infection Diseases, General Surgery, Orthopedic, Neurology, and Others)

The Asia Pacific medical device coating market is expected to grow from US$ 1,834.27 million in 2022 to US$ 2,945.07 million by 2028. It is estimated to register a CAGR of 8.2% from 2022 to 2028.

Increasing R&D Activities and Innovation in Medical Device Coating Materials is Driving the Asia Pacific Medical Device Coating Market

Medical device coatings range from lubrications to antimicrobials and water-repellent polymers and can be customized according to the device’s type. Intense R&D activities bring to the surface some innovative coated surgical devices. The coating binds water molecules, creating a thin hydration barrier that deters microbes from binding and proliferation. These coatings are expected not to harm the tissues and eliminate implant-associated infections. Parylene, medical-grade polytetrafluoroethylene (PTFE), and albumin coatings are advantageous over traditional titanium nitride and physical vapor deposition (PVD) coatings. Such research and development activities in medical device coatings are likely to propel the Asia Pacific medical device coating market growth.

Asia Pacific Medical Device Coating Market Overview

The Asia Pacific medical device coating market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. A surge in industrialization activities in emerging Asia Pacific countries and favorable policies implemented by the government of India, such as Foreign Direct Investment (FDI) and Make in India, are expected to create growth opportunities for the market players across the region. Moreover, increasing geriatric population, rising burden of chronic disorders, surging healthcare expenditure, and increasing surgical procedures are expected to boost the growth of the medical device coating market in the region. China is a well-developed country in Asia Pacific, has a well-established healthcare system, and is one of the leading producers of medical devices in the region. The country has an increasing burden of diseases such as obesity, cardiovascular disorders, and orthopedic disorders owing to the presence of a large geriatric population. As per the Lancet Public Health Journal 2020, China has experienced ~4 million deaths due to cardiovascular disorders. Additionally, the market growth is attributed to the presence of a large geriatric population prone to orthopedic conditions and joint replacement procedures, a surge in surgical procedures, an increase in healthcare expenditure, and investment in the development of advanced coatings to avoid healthcare-associated infections and surgical site infections. Asia Pacific Journal of Tropical Medicine 2020 states that a population-based epidemiological survey of sepsis found that the incidence rate of severe sepsis is 270 per 100,000, and the mortality rate was 26%. Based on this situation, Chinese emergency medicine experts proposed the concept of “preventing and blocking” sepsis and launched the “Preventing Sepsis Campaign in China (PSCC).”

Asia Pacific Medical Device Coating Market Revenue and Forecast to 2028 (US$ Million)    

Asia Pacific Medical Device Coating Market Segmentation

The Asia Pacific medical device coating market is segmented into material type, devices, coating, application, and country. Based on material type, the market is segmented into polymers, metals, and others. The metals segment registered the largest market share in 2022.

• Based on devices, the Asia Pacific medical device coating market is segmented into medical equipment and tools, medical devices, medical implants, and others. The medical devices segment registered the largest market share in 2022.
• Based on coating, the Asia Pacific medical device coating market is segmented into hydrophilic coatings, anti-microbial coatings, drug-eluting coatings, anti-thrombogenic coatings, and others. The hydrophilic coatings segment registered the largest market share in 2022.
• Based on application, the Asia Pacific medical device coating market is segmented into infectious diseases, neurology, orthopedics, general surgery, and others. The others segment registered the largest market share in 2022.
• Based on country, the Asia Pacific medical device coating market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. China dominated the market share in 2022.

Covalon Technologies Ltd, Harland Medical Systems Inc, Hydromer Inc, Kisco Ltd, Koninklijke DSM NV, and Surmodics Inc are among the leading companies operating in the medical device coating market in the region.   

1. Covalon Technologies Ltd
2. Harland Medical Systems Inc
3.  Hydromer Inc
4. Kisco Ltd
5. Koninklijke DSM NV
6. Surmodics Inc

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific medical device coating market.       
• Highlights key business priorities in order to assist companies to realign their business strategies
• The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific medical device coating market, thereby allowing players across the value chain to develop effective long-term strategies
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
• Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the medical device coating market, as well as those hindering it
• Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution